(HON) Honeywell International - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4385161066
Stock: Aerospace, Automation, Building, Energy
Total Rating 59
Risk 86
Buy Signal -0.46
| Risk 5d forecast | |
|---|---|
| Volatility | 21.8% |
| Relative Tail Risk | -7.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.71 |
| Alpha | 9.37 |
| Character TTM | |
|---|---|
| Beta | 0.650 |
| Beta Downside | 0.515 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.10% |
| CAGR/Max DD | 0.51 |
EPS (Earnings per Share)
Revenue
Description: HON Honeywell International March 04, 2026
Honeywell International Inc. operates across four primary segments: Aerospace Technologies, Industrial Automation, Building Automation, and Energy and Sustainable Solutions. The company provides a diverse range of products and services globally.
The Aerospace Technologies segment supplies components and services for aircraft, including propulsion engines and avionics. This sector is characterized by long product lifecycles and high regulatory barriers to entry.
Industrial Automation offers control systems, sensing technologies, and software for manufacturing and logistics. This business model often involves recurring revenue from software licenses and maintenance contracts.
Building Automation focuses on building control and optimization, including energy management and security systems. Demand in this segment is often tied to new construction and retrofitting projects.
The Energy and Sustainable Solutions segment, via its UOP business, provides process technology and catalysts for refining, petrochemicals, and low-carbon energy. This segment benefits from global energy transition initiatives.
Further analysis of Honeywells financial performance and market position can be found on ValueRay.
Headlines to watch out for
- Aerospace demand drives revenue growth
- Industrial automation spending impacts segment performance
- Building efficiency solutions increase market share
- Energy transition technologies expand UOPs reach
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 5.14b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.72 > 1.0 |
| NWC/Revenue: 18.37% < 20% (prev 17.28%; Δ 1.09% < -1%) |
| CFO/TA 0.09 > 3% & CFO 6.38b > Net Income 5.14b |
| Net Debt (20.55b) to EBITDA (9.48b): 2.17 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (638.6m) vs 12m ago -2.47% < -2% |
| Gross Margin: 36.93% > 18% (prev 0.38%; Δ 3654 % > 0.5%) |
| Asset Turnover: 54.03% > 50% (prev 51.19%; Δ 2.84% > 0%) |
| Interest Coverage Ratio: 5.90 > 6 (EBITDA TTM 9.48b / Interest Expense TTM 1.35b) |
Altman Z'' 4.00
| A: 0.10 (Total Current Assets 30.83b - Total Current Liabilities 23.42b) / Total Assets 74.11b |
| B: 0.72 (Retained Earnings 53.50b / Total Assets 74.11b) |
| C: 0.11 (EBIT TTM 7.94b / Avg Total Assets 74.66b) |
| D: 0.26 (Book Value of Equity 15.44b / Total Liabilities 58.67b) |
| Altman-Z'' Score: 4.00 = AA |
Beneish M -3.06
| DSRI: 0.93 (Receivables 7.62b/7.82b, Revenue 40.34b/38.50b) |
| GMI: 1.04 (GM 36.93% / 38.34%) |
| AQI: 0.95 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.05 (Revenue 40.34b / 38.50b) |
| TATA: -0.02 (NI 5.14b - CFO 6.38b) / TA 74.11b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of HON shares?
As of March 09, 2026, the stock is trading at USD 235.29 with a total of 2,919,645 shares traded.
Over the past week, the price has changed by -5.14%, over one month by -1.41%, over three months by +23.16% and over the past year by +19.26%.
Over the past week, the price has changed by -5.14%, over one month by -1.41%, over three months by +23.16% and over the past year by +19.26%.
Is HON a buy, sell or hold?
Honeywell International has received a consensus analysts rating of 3.92.
Therefore, it is recommended to buy HON.
- StrongBuy: 11
- Buy: 2
- Hold: 13
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 251 | 6.7% |
| Analysts Target Price | 251 | 6.7% |
HON Fundamental Data Overview March 07, 2026
P/E Trailing = 31.0409
P/E Forward = 23.2019
P/S = 4.2347
P/B = 10.1142
P/EG = 2.2333
Revenue TTM = 40.34b USD
EBIT TTM = 7.94b USD
EBITDA TTM = 9.48b USD
Long Term Debt = 30.09b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.89b USD (from shortTermDebt, last quarter)
Debt = 33.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.55b USD (from netDebt column, last quarter)
Enterprise Value = 178.66b USD (158.55b + Debt 33.03b - CCE 12.93b)
Interest Coverage Ratio = 5.90 (Ebit TTM 7.94b / Interest Expense TTM 1.35b)
EV/FCF = 33.13x (Enterprise Value 178.66b / FCF TTM 5.39b)
FCF Yield = 3.02% (FCF TTM 5.39b / Enterprise Value 178.66b)
FCF Margin = 13.37% (FCF TTM 5.39b / Revenue TTM 40.34b)
Net Margin = 12.74% (Net Income TTM 5.14b / Revenue TTM 40.34b)
Gross Margin = 36.93% ((Revenue TTM 40.34b - Cost of Revenue TTM 25.44b) / Revenue TTM)
Gross Margin QoQ = 35.56% (prev 34.08%)
Tobins Q-Ratio = 2.41 (Enterprise Value 178.66b / Total Assets 74.11b)
Interest Expense / Debt = 1.14% (Interest Expense 376.0m / Debt 33.03b)
Taxrate = 17.98% (1.07b / 5.95b)
NOPAT = 6.52b (EBIT 7.94b * (1 - 17.98%))
Current Ratio = 1.32 (Total Current Assets 30.83b / Total Current Liabilities 23.42b)
Debt / Equity = 2.14 (Debt 33.03b / totalStockholderEquity, last quarter 15.44b)
Debt / EBITDA = 2.17 (Net Debt 20.55b / EBITDA 9.48b)
Debt / FCF = 3.81 (Net Debt 20.55b / FCF TTM 5.39b)
Total Stockholder Equity = 16.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.88% (Net Income 5.14b / Total Assets 74.11b)
RoE = 31.25% (Net Income TTM 5.14b / Total Stockholder Equity 16.45b)
RoCE = 17.07% (EBIT 7.94b / Capital Employed (Equity 16.45b + L.T.Debt 30.09b))
RoIC = 12.47% (NOPAT 6.52b / Invested Capital 52.24b)
WACC = 7.04% (E(158.55b)/V(191.59b) * Re(8.31%) + D(33.03b)/V(191.59b) * Rd(1.14%) * (1-Tc(0.18)))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.70%
[DCF] Terminal Value 82.71% ; FCFF base≈5.21b ; Y1≈5.64b ; Y5≈7.00b
[DCF] Fair Price = 203.4 (EV 149.67b - Net Debt 20.55b = Equity 129.13b / Shares 634.9m; r=7.04% [WACC]; 5y FCF grow 9.35% → 2.90% )
EPS Correlation: 81.20 | EPS CAGR: 8.46% | SUE: 0.51 | # QB: 0
Revenue Correlation: 90.69 | Revenue CAGR: 4.16% | SUE: -0.81 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.56 | Chg7d=-0.000 | Chg30d=-0.004 | Revisions Net=-2 | Analysts=16
EPS current Year (2026-12-31): EPS=10.54 | Chg7d=-0.005 | Chg30d=+0.003 | Revisions Net=+7 | Growth EPS=+7.7% | Growth Revenue=+5.6%
EPS next Year (2027-12-31): EPS=11.50 | Chg7d=+0.002 | Chg30d=+0.058 | Revisions Net=+7 | Growth EPS=+9.1% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: -0.20 (4 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 8.3% - Earnings Yield 3.2%)
[Growth] Growth Spread = -11.2% (Analyst -6.1% - Implied 5.1%)
P/E Forward = 23.2019
P/S = 4.2347
P/B = 10.1142
P/EG = 2.2333
Revenue TTM = 40.34b USD
EBIT TTM = 7.94b USD
EBITDA TTM = 9.48b USD
Long Term Debt = 30.09b USD (from longTermDebt, two quarters ago)
Short Term Debt = 5.89b USD (from shortTermDebt, last quarter)
Debt = 33.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.55b USD (from netDebt column, last quarter)
Enterprise Value = 178.66b USD (158.55b + Debt 33.03b - CCE 12.93b)
Interest Coverage Ratio = 5.90 (Ebit TTM 7.94b / Interest Expense TTM 1.35b)
EV/FCF = 33.13x (Enterprise Value 178.66b / FCF TTM 5.39b)
FCF Yield = 3.02% (FCF TTM 5.39b / Enterprise Value 178.66b)
FCF Margin = 13.37% (FCF TTM 5.39b / Revenue TTM 40.34b)
Net Margin = 12.74% (Net Income TTM 5.14b / Revenue TTM 40.34b)
Gross Margin = 36.93% ((Revenue TTM 40.34b - Cost of Revenue TTM 25.44b) / Revenue TTM)
Gross Margin QoQ = 35.56% (prev 34.08%)
Tobins Q-Ratio = 2.41 (Enterprise Value 178.66b / Total Assets 74.11b)
Interest Expense / Debt = 1.14% (Interest Expense 376.0m / Debt 33.03b)
Taxrate = 17.98% (1.07b / 5.95b)
NOPAT = 6.52b (EBIT 7.94b * (1 - 17.98%))
Current Ratio = 1.32 (Total Current Assets 30.83b / Total Current Liabilities 23.42b)
Debt / Equity = 2.14 (Debt 33.03b / totalStockholderEquity, last quarter 15.44b)
Debt / EBITDA = 2.17 (Net Debt 20.55b / EBITDA 9.48b)
Debt / FCF = 3.81 (Net Debt 20.55b / FCF TTM 5.39b)
Total Stockholder Equity = 16.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.88% (Net Income 5.14b / Total Assets 74.11b)
RoE = 31.25% (Net Income TTM 5.14b / Total Stockholder Equity 16.45b)
RoCE = 17.07% (EBIT 7.94b / Capital Employed (Equity 16.45b + L.T.Debt 30.09b))
RoIC = 12.47% (NOPAT 6.52b / Invested Capital 52.24b)
WACC = 7.04% (E(158.55b)/V(191.59b) * Re(8.31%) + D(33.03b)/V(191.59b) * Rd(1.14%) * (1-Tc(0.18)))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.70%
[DCF] Terminal Value 82.71% ; FCFF base≈5.21b ; Y1≈5.64b ; Y5≈7.00b
[DCF] Fair Price = 203.4 (EV 149.67b - Net Debt 20.55b = Equity 129.13b / Shares 634.9m; r=7.04% [WACC]; 5y FCF grow 9.35% → 2.90% )
EPS Correlation: 81.20 | EPS CAGR: 8.46% | SUE: 0.51 | # QB: 0
Revenue Correlation: 90.69 | Revenue CAGR: 4.16% | SUE: -0.81 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.56 | Chg7d=-0.000 | Chg30d=-0.004 | Revisions Net=-2 | Analysts=16
EPS current Year (2026-12-31): EPS=10.54 | Chg7d=-0.005 | Chg30d=+0.003 | Revisions Net=+7 | Growth EPS=+7.7% | Growth Revenue=+5.6%
EPS next Year (2027-12-31): EPS=11.50 | Chg7d=+0.002 | Chg30d=+0.058 | Revisions Net=+7 | Growth EPS=+9.1% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: -0.20 (4 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 8.3% - Earnings Yield 3.2%)
[Growth] Growth Spread = -11.2% (Analyst -6.1% - Implied 5.1%)